Case Citation: A24086734 | Decision Year: 2024 | Judge: Jonathan Hager

A Vietnam veteran walked into a December 2024 Board hearing with ten claims on appeal. He walked out with two grants, four denials, and four remands. The two grants were both cancers tied to Agent Orange. One of the denials was anemia, and he had argued anemia on the same Agent Orange theory.

Same veteran. Same exposure. Same VA examiner. Same Board judge. Two cancers granted, anemia denied.

That is not a contradiction. It is the presumptive list working exactly as designed, and it is one of the most important and least-understood mechanics in the entire VA claims system. I want to walk through why this veteran's anemia claim failed, because if you are filing on a toxic exposure theory and your condition is not on the presumptive list, you are going to be standing in roughly the same place he was.

The Hook

The veteran served on active duty in the Army from May 1969 to February 1971, including service in Vietnam. That puts him squarely in the population of veterans who are presumed to have been exposed to herbicide agents under longstanding VA regulations. He does not have to prove Agent Orange exposure. VA stipulates it.

In 2024, VA readjudicated ten of his claims after finding new and relevant evidence. The Regional Office denied most of them on the merits. He appealed to the Board, picked the hearing docket, and testified before Veterans Law Judge Jonathan Hager in October 2024.

Two of his claims, left lung cancer and colon cancer, came back as grants. The lung cancer was granted on a presumptive basis because lung cancer is one of the diseases on the Agent Orange list. The colon cancer was granted on a direct basis, because colon cancer is not on the presumptive list, but a private physician and a VA examiner offered competing opinions and the Board found the evidence in equipoise.

The anemia claim was denied. The reason is simple: anemia is not on the Agent Orange presumptive list, and the VA examiner specifically opined that "Agent Orange exposure is not known to cause iron deficiency anemia or low folate levels." Without a presumptive pathway and without a favorable nexus opinion, the claim had nothing left to stand on.

This is a denial case. It is also a case study in why two veterans with identical exposure histories can get opposite results on different conditions in the same decision, and what that means for how you should think about toxic-exposure claims that fall outside the presumptive framework.

What Happened (The Quick Version)

  • Service: United States Army, active duty May 1969 to February 1971, including service in Vietnam. Presumed exposure to herbicide agents.
  • Claims on appeal: Ten total. Left lung cancer, colon cancer, asthma, primary open angle glaucoma, PTSD, anemia, right knee, left knee, bilateral foot disability (pes planus), and GERD.
  • Outcome: Two grants (lung cancer, colon cancer). Four denials (asthma, glaucoma, PTSD, anemia). Four remands (right knee, left knee, foot, GERD).
  • Anemia denial basis: No presumptive pathway. No favorable nexus opinion. VA examiner concluded Agent Orange exposure is not known to cause iron deficiency anemia or low folate levels.
  • Connection theory attempted: Presumptive, based on Vietnam Agent Orange exposure.
  • Nexus quality: Weak. The only medical opinion in the record on anemia was the VA examiner's negative opinion.
  • C&P exam: Adequate. The Board found the December 2023 TERA examination report sufficient.
  • Lay evidence on anemia specifically: Not addressed in the structured record.
  • Procedural posture: One prior denial. Readjudicated in 2024 after new and relevant evidence finding. Hearing docket. Williams/Clark waiver of remaining time periods on the record.

Why This Matters to You

If you served in Vietnam, in the Persian Gulf, around burn pits, near contaminated water at Camp Lejeune, or in any other recognized toxic exposure environment, you have probably been told that "Agent Orange covers everything" or "PACT Act covers everything." It does not. Each of those exposure programs has a specific list of conditions it covers presumptively, and conditions outside the list have to win on direct or secondary theories with actual nexus evidence. This case shows exactly what happens when a claim falls into that gap. If you have a condition you suspect is exposure-related but it is not on a presumptive list, the path forward is real but it is harder, and the burden of proof shifts back onto you.

Why This Case Matters

  • Presumptive lists are finite, not flexible. The Board did not deny anemia because it doubted the exposure. It denied anemia because the regulation listing presumptive diseases does not include it, and the medical evidence in the record specifically said Agent Orange does not cause iron deficiency anemia. Presumption is a regulatory shortcut, not a general principle.
  • The same exposure, the same examiner, and the same judge can produce opposite results on different conditions. This veteran won lung cancer presumptively, won colon cancer on direct theory because of a favorable private opinion, and lost anemia because there was no presumptive pathway and no favorable opinion. The variable is not the exposure. The variable is what each claim has in its file.
  • A single TERA examination can both win and lose claims for you. The December 2023 VA TERA examiner gave this veteran favorable opinions on lung cancer and unfavorable opinions on asthma, glaucoma, and anemia. The exam was the same. The conclusions varied condition by condition.
  • Without a favorable nexus opinion on a non-presumptive condition, the claim is structurally weak. Anemia had one medical opinion in the file, and it was negative. There was no private physician letter, no medical literature offered by the veteran, no lay continuity-of-symptoms theory. The file had nothing to set against the examiner.

What the Board Said

On the framework for service connection:

Service connection will be granted if the evidence demonstrates that current disability resulted from an injury or disease incurred in the active military, naval, air, or space service. Establishing service connection generally requires competent evidence of three things: (1) current disability; (2) in-service disease or injury; and (3) a causal relationship between the current disability and the in-service disease or injury.

Three elements. Current disability. In-service event or exposure. Nexus between the two. For most claims, the veteran has to prove all three. Presumptive service connection is a regulatory shortcut that lets a veteran skip the nexus element if the condition is on a list and the exposure is recognized.

On the December 2023 TERA examiner's conclusion regarding anemia:

The examiner noted that Agent Orange exposure is not known to cause iron deficiency anemia or low folate levels.

That sentence is the entire denial. The examiner did not say the anemia did not exist. The examiner said the medical literature does not connect Agent Orange to iron deficiency anemia. No connection, no nexus. No nexus, no service connection.

On how the Board weighed the lone medical opinion:

The Board's pattern throughout this decision was the same on every non-presumptive condition: when there is one medical opinion and no contrary opinion, the Board accepts it. On the asthma claim (denied on similar grounds), the Board wrote that the VA opinion was "persuasive evidence" because the examiner "explained the reasons for his conclusion based on an accurate characterization of the evidence of record." The same logic applied to anemia. One opinion, no counter, denial.

The implication for the anemia claim is straightforward. There was no private physician letter offered for anemia. There was no medical literature submitted. The veteran's hearing testimony focused on Agent Orange exposure as a general theory, not on a specific medical pathway connecting Agent Orange to iron deficiency anemia. The file had a negative opinion and nothing else.

The First Precedent: Nieves-Rodriguez v. Peake (2008). Reasoning Is Where Probative Weight Lives

Nieves-Rodriguez v. Peake, 22 Vet. App. 295 (2008) is the case that tells VA adjudicators how to weigh medical opinions. The rule in plain English: most of the probative value of a medical opinion comes from the reasoning that supports the conclusion, not from the credentials of the person who wrote it. An opinion from a private physician with a detailed explanation can outweigh a VA examiner's conclusory note. An opinion from a VA examiner with detailed reasoning can outweigh a private physician's bare assertion.

Judge Hager cited Nieves-Rodriguez at three different points in this decision. On the colon cancer grant, he used it to find that competing opinions were in equipoise (private doctor and VA examiner both gave reasoned opinions, so neither outweighed the other, and the tie went to the veteran). On the lung cancer grant, he used it to credit both the private opinion and the VA examiner's favorable opinion. On the asthma and glaucoma denials, he used it to credit the VA examiner's negative opinion because no contrary medical opinion existed in the record.

The anemia denial follows the same pattern. The VA examiner gave reasoned, literature-based grounds for the negative opinion. No contrary opinion existed. Under Nieves-Rodriguez, the Board found the examiner's reasoning persuasive and the claim was denied.

The practical lesson: if you are filing on a non-presumptive condition and you do not have a favorable medical opinion in your file, you are not in equipoise. You are in a structural deficit. The presumption of equal weight that some veterans assume between "VA says no" and "I say yes" does not exist in the regulation. The Board weighs opinions, not assertions.

The Second Precedent: Jandreau v. Nicholson (Fed. Cir. 2007). The Limits of Lay Competence

Jandreau v. Nicholson, 492 F.3d 1372 (Fed. Cir. 2007) is the case that defines what veterans can and cannot competently testify about. The rule in plain English: a veteran is always competent to describe what he or she observed (symptoms, events, duties, what happened day-to-day). A veteran is sometimes competent to identify a condition when it is "simple" (the Court used a broken leg as the example). A veteran is generally not competent to opine on the etiology of complex medical conditions, especially when the cause-and-effect relationship is not immediately observable.

Judge Hager applied Jandreau directly to the glaucoma denial in this case, quoting the rule about laypersons and complex medical conditions:

sometimes the layperson will be competent to identify the condition where the condition is simple, for example a broken leg, and sometimes not, for example, a form of cancer.

The same logic applies in principle to anemia. The veteran can testify that he was exposed to Agent Orange. He can testify that he has been diagnosed with anemia. He cannot competently opine that Agent Orange caused his iron deficiency anemia, because that is a complex etiological question involving internal hematological processes that are not immediately observable.

This is not VA being dismissive of veterans. It is the Federal Circuit drawing a line that applies to every party in a courtroom. A layperson cannot give expert medical opinion testimony in any forum. The way around the line is not to argue louder. The way around the line is to put a qualified medical opinion into the file.

The Third Precedent: Buchanan v. Nicholson (Fed. Cir. 2006). Lay Testimony on Continuity of Symptoms

Buchanan v. Nicholson, 451 F.3d 1331 (Fed. Cir. 2006) is the companion to Jandreau. It stands for the proposition that a veteran's lay testimony about continuity of symptoms cannot be discounted simply because the symptoms are not corroborated in the medical records. If a veteran credibly testifies that a condition has bothered him continuously since service, that testimony is competent evidence of continuity even if the contemporaneous records are silent.

The Board cited Buchanan in this decision on the glaucoma claim, noting that the veteran had not indicated continuous glaucoma symptoms since service. On the anemia claim, the same continuity theory was apparently not raised. The veteran did not testify that he had experienced anemia symptoms (fatigue, pallor, shortness of breath on exertion attributable to low hemoglobin) continuously since his Vietnam service. The hearing transcript focused on the Agent Orange exposure narrative, not on a symptom timeline.

The lesson here is one of the most actionable in the whole decision. If you are filing on a non-presumptive condition tied to a toxic exposure, and you genuinely have experienced the symptoms continuously since service, say so. On the record. With dates and specifics. Buchanan gives that testimony evidentiary weight even when the medical records do not corroborate it. Silence on the symptom timeline is not the same as testimony that there was no timeline. But silence is what the Board sees, and silence does not help you.

The Four Denial Mechanics, In Detail

The Board did not write a long anemia section. It did not need to. The denial rested on a small number of specific gaps in the file. Each of these is worth understanding because each represents an evidentiary move the veteran could potentially have made and did not.

  • No presumptive pathway. Anemia is not on the Agent Orange presumptive list under the regulation governing presumptive diseases for herbicide-exposed veterans. The list includes specific conditions like various cancers, ischemic heart disease, Parkinson's, and others, but iron deficiency anemia is not among them. Without presumption, the claim required proof of nexus by competent medical evidence.
  • No favorable nexus opinion. The only medical opinion on anemia in the file was the December 2023 VA TERA examiner's negative opinion. No private physician offered a letter on anemia. The January 2011 letter from the private doctor that supported the lung cancer and colon cancer claims did not address anemia. The file was one-sided.
  • No medical literature in the record. The VA examiner cited published sources (the Cleveland Clinic for lung cancer, the National Institutes of Health for colon cancer) as part of his reasoning. The veteran did not submit countervailing literature suggesting an Agent Orange to anemia pathway. The published medical literature on Agent Orange health effects does discuss certain hematological conditions, but the veteran did not put any of that discussion into his file.
  • No continuity-of-symptoms testimony specific to anemia. The hearing testimony summarized in the decision focused on asthma being misdiagnosed and on Agent Orange exposure generally. There is no indication in the record that the veteran testified about anemia symptoms dating back to service or arising shortly after separation. Under Buchanan, that testimony, if credibly offered, would have been competent evidence. It was not offered.

Each gap is independent. Closing any one of them would have changed the analytical landscape of the claim. Closing none of them produced the denial.

A grounded reset before the lessons

Everything above is what happened to one Vietnam veteran in one decision. Here is what it means for you if your file looks anything like his.

Lesson #1: A Presumptive List Is a Closed List

The most common misconception I see across the dataset is the assumption that recognized toxic exposure (Agent Orange, burn pits, Camp Lejeune water, ionizing radiation) operates as a general theory of liability for any downstream condition. It does not. Each exposure program has a regulation that lists specific diseases. Conditions on the list get presumptive service connection if you meet the exposure criteria. Conditions off the list get nothing automatically.

For Agent Orange, the list under the regulation governing presumptive herbicide-related diseases currently includes specific cancers (lung, bronchus, larynx, trachea, prostate, certain soft tissue sarcomas, certain B-cell leukemias, multiple myeloma, Hodgkin and non-Hodgkin lymphomas, bladder, and others), Parkinson's disease and Parkinsonism, ischemic heart disease, chloracne, peripheral neuropathy (early-onset), porphyria cutanea tarda, AL amyloidosis, type 2 diabetes, hypothyroidism, and hypertension (added under the PACT Act). Anemia is not there. Asthma is not there. Glaucoma is not there. GERD is not there.

When you file a claim citing Agent Orange (or any other recognized exposure), the very first thing you should do is open the regulation and look at the current presumptive list. If your condition is on it, you are in a structurally strong position. If your condition is not on it, you are filing a direct service connection claim that happens to involve a recognized exposure, and you need to build the file accordingly.

Lesson #2: For Non-Presumptive Conditions, You Need a Favorable Medical Opinion

The colon cancer claim in this decision is the model for how to win on a non-presumptive theory. Colon cancer is not on the Agent Orange list. The veteran won anyway, because a private physician (Dr. J.M.) wrote a January 2011 letter saying that "there is an association between colon cancer and herbicide agent exposure" and the Board found that opinion in equipoise with the VA examiner's contrary opinion.

The anemia claim had no Dr. J.M. letter. No medical opinion in the file said Agent Orange caused or contributed to the anemia. Under Nieves-Rodriguez, the one opinion that did exist (the VA examiner's negative opinion) controlled.

The practical lesson is simple: if you are pursuing a non-presumptive condition on a toxic exposure theory, a favorable medical opinion is not a nice-to-have. It is the file. Without it, you have a negative VA opinion and nothing to set against it.

The opinion does not have to come from a famous specialist. It needs to come from a competent medical professional who has reviewed the relevant records, who states a conclusion in "at least as likely as not" terms, and who provides reasoning that ties the exposure to the condition. The reasoning is what makes it probative under Nieves-Rodriguez. A two-line conclusory letter will be discounted. A two-page letter with citations and an explanation of the proposed mechanism will be weighed.

Lesson #3: Lay Testimony About Continuity Is Free Evidence You Should Not Skip

I do not know whether this veteran experienced continuous anemia symptoms since Vietnam. The Board's summary of his hearing testimony does not mention anemia symptoms over time. If he did experience symptoms continuously, he had a chance to put that on the record under Buchanan and apparently did not.

Lay testimony about your own symptoms over time is evidence. It is not a substitute for a medical opinion on causation, but it can be the difference between a record that supports continuity and a record that is silent. The Board cannot grant on the basis of testimony you did not give.

If you are preparing for a hearing or drafting a supplemental claim on a chronic condition you believe is exposure-related, ask yourself: when did the symptoms start, what did they look like, have they continued, and can I describe them concretely? If yes, write it down with dates. Submit it. Testify about it at the hearing. It is one of the lowest-cost, highest-leverage pieces of evidence available to you, and it costs nothing but the time it takes to think clearly about your own history.

(I am using the word "leverage" in the financial sense of a position with high marginal impact. If that bothers anyone, swap in "force multiplier." Same idea.)

Actually, scratch that aside. The lesson is the lesson. Lay testimony about your symptom timeline matters. Give it.

Lesson #4: The Same Exam Can Win and Lose Different Claims

The December 2023 VA TERA examination in this case is a useful study. The examiner gave a favorable opinion on lung cancer (citing the Cleveland Clinic for the herbicide-respiratory cancer association). The examiner gave a negative opinion on colon cancer (citing the NIH for the absence of an association). The examiner gave negative opinions on asthma, glaucoma, and anemia (citing the absence of medical literature linking each condition to herbicide exposure).

One examiner. One exam. Five different conditions assessed. Favorable on one, negative on four. The Board accepted the favorable opinion on lung cancer, found the negative opinion on colon cancer to be in equipoise with the private opinion (and granted), and accepted the negative opinions on asthma, glaucoma, and anemia (and denied).

The takeaway is that a TERA exam is not a single verdict on your case. It is a per-condition analysis, and the result depends on what the published medical literature says about each specific condition. Going into a TERA exam, it can be worth knowing in advance which of your claimed conditions are on solid presumptive ground, which have published medical literature supporting an exposure association, and which are likely to draw negative opinions. That awareness lets you make informed decisions about which claims to pursue aggressively, which to support with additional private opinions, and which may be structurally weak no matter what the exam concludes.

Lesson #5: A Single Decision Can Contain Wins, Losses, and Remands. Read All Three Buckets

This veteran's decision contained two grants, four denials, and four remands. Each bucket is doing something different, and a veteran reading the decision needs to understand all three.

The grants (lung cancer, colon cancer) are final and binding. Service connection is established. The next step is rating, which will happen at the Regional Office.

The denials (asthma, glaucoma, PTSD, anemia) are final on the existing record but can be reopened with new and relevant evidence under the supplemental claim process. If this veteran obtains a private medical opinion on his anemia later, or if new medical literature emerges connecting Agent Orange to iron deficiency anemia, he can file a supplemental claim and try again. The denial is not the end of the road, but it is a reset point.

The remands (right knee, left knee, foot, GERD) are the Board sending issues back to the RO for additional development. They are neither wins nor losses. They are work orders. The RO will do whatever the Board's remand instructions specify and then issue a new decision on those issues.

If you receive a mixed decision like this one, the most important thing is to separate the buckets cleanly and know what to do about each. Celebrate the grants and prepare for the rating phase. Take the denials seriously and ask whether you can build a stronger file for a supplemental claim. Track the remands and stay engaged with the RO development process.

Lesson #6: Hearing Testimony Is Strategic, Not Just Narrative

The summary of this veteran's October 2024 hearing testimony in the decision is brief. He testified that what he thought was asthma was actually the beginning of lung cancer. He testified that his glaucoma was due to Agent Orange covering his glasses. He testified generally about being doused with Agent Orange.

Some of that testimony was useful. The general exposure narrative reinforced the existing presumption of exposure (though the presumption did not need reinforcing). The asthma-was-actually-lung-cancer theory did not help, because the lung cancer was already granted on presumptive grounds and the asthma diagnosis was independently documented.

What is missing from the summary is condition-specific testimony for the denied conditions. There is no indication that the veteran testified about the timeline of his anemia symptoms, about specific incidents during service that might be relevant to his glaucoma beyond the general Agent Orange theory, or about a stressor narrative for the PTSD claim that meets the regulatory criteria. Hearing time is finite. If you get a hearing, every minute of testimony should be doing specific work on a specific claim.

The practical recommendation: before a Board hearing, work with your representative to outline what each claim needs and what testimony you can offer that addresses those specific needs. General exposure narratives are easy and feel substantive in the moment, but they rarely move a denied claim into grant territory. Specific symptom-timeline testimony, specific incident-and-injury testimony, and specific functional-impact testimony are where hearings produce results.

One more grounded reset before the action steps

If your file looks like this veteran's on any of his denied conditions, the next part is what matters most.

What If This Was You

If you are filing on a toxic exposure theory and you suspect your condition may be outside the presumptive list, here is the order of operations.

  1. Identify the presumptive list that applies to your exposure. Agent Orange has one list. Camp Lejeune has another. Burn pits and the PACT Act have a third. Radiation has a fourth. The lists are not interchangeable. Read the actual regulation, not a blog summary, for whatever exposure applies to you.
  2. Check whether your condition is on the list. If yes, your file is structurally strong, and presumptive service connection is your primary theory. If no, you are in direct-service-connection territory and the burden shifts back to you.
  3. For non-presumptive conditions, obtain a medical opinion before you file (or before you appeal). A private physician opinion that addresses the specific exposure and the specific condition, with reasoning, is the single most valuable piece of evidence you can add. Without it, you are relying on the VA examiner to be favorable, and TERA examiners often will not be on non-presumptive conditions.
  4. Document your symptom timeline in writing. If you have experienced the condition's symptoms continuously since service or shortly after, write a dated statement describing what you experienced and when. Submit it. Testify about it at any hearing.
  5. If you go to a hearing, plan the testimony per claim. What does each denied or contested claim need? Continuity? A specific incident? Functional impact? Use the hearing time to deliver those specifics, not to repeat the general exposure story the Board already accepts.
  6. If you receive a denial on a non-presumptive condition, treat it as the start of a supplemental claim, not the end of the road. Identify what was missing (usually a favorable opinion or a continuity statement) and build that into a supplemental claim under VA Form 20-0995.

What the Data Can't Tell Me

A few honest limits on what I can conclude from this decision.

I do not have the underlying medical records. I have the Board's summary of what they contained. The Board's characterization may not capture every nuance of the file, and I am working from that characterization.

I do not know whether this veteran had any private medical opinion on anemia that did not make it into the record, or whether he tried to obtain one and could not. The structured evidence list shows only the VA exam and service treatment records, but I cannot rule out that other evidence was offered and either rejected or not addressed in the decision.

I do not know whether the medical literature on Agent Orange and anemia is genuinely silent or whether the VA examiner's literature review was incomplete. The examiner cited the absence of medical evidence linking the two. That is a conclusion about the state of the literature as of late 2023. If new studies emerge, the calculus could change for future supplemental claims.

Bottom Line

The anemia denial in BVA A24086734 is not a story about a veteran who was treated unfairly or about a Board that ignored his service. It is a story about how the presumptive framework actually works. Presumptive service connection is a list. The list is finite. Conditions on the list get the shortcut. Conditions off the list have to win on the merits, and winning on the merits requires a medical opinion that ties the exposure to the condition.

This veteran got that shortcut on lung cancer and got it on colon cancer through a competing private opinion that produced equipoise. He did not get it on anemia because he did not have a private opinion on anemia and the anemia is not on the list. The result is consistent with the regulation, consistent with the case law, and consistent with how the Board treats this category of claim across the dataset.

If you are pursuing a toxic-exposure claim on a non-presumptive condition, the path is real but it runs through a favorable medical opinion. Build the file first. File the claim second. Skipping that order is how denials like this one happen.

Methodology and Limitations

  • Data source: Claim Raven's analysis of BVA citation A24086734, a single Board of Veterans' Appeals decision dated December 31, 2024, written by Veterans Law Judge Jonathan Hager.
  • Verbatim quotes: All blockquoted passages and the examiner's negative opinion language come from the structured key_quotes field and from the verbatim Reasons and Bases section of the decision.
  • Aggregate context: This is a single-case breakdown. Where I reference broader patterns, those patterns come from Claim Raven's larger dataset of 101,518 condition records drawn from the analyzed subset of Claim Raven's 501,000+ Board-decision library. Individual outcomes vary substantially and cannot be predicted from aggregate data alone.

Disclaimer

I'm not accredited by VA, not a lawyer, not a VSO. This is data analysis, not claim advice. These are patterns from cases that made it to the BVA, they don't predict individual outcomes. If you need help with your claim, work with an accredited representative.

Where to go next

-Landon Founder, Claim Raven | U.S. Army Veteran